PURAPHARM (01498) proposes appointing Zhongzheng Tianheng CPA as the new auditor.
PuraPharm (01498) announced that on September 15, 2026, the Company's current auditor, BDO Limited, resigned as the Company's auditor with effect from the conclusion of the forthcoming general meeting, after the Company's management issued a notice regarding the Board's proposal to change the auditor due to audit fee considerations. In addition, upon the recommendation of the audit committee, the Board has proposed to appoint Zhongzheng Tianheng CPA Limited as the Company's new auditor following BDO's resignation, subject to approval by the shareholders at the Company's extraordinary general meeting.
PURAPHARM (01498) announces that on September 15, 2026, the Company's current auditor, BDO Limited, resigned as the Company's auditor following a notice issued by the Company's management regarding the Board's recommendation to change the auditor due to audit fee considerations, effective from the conclusion of the forthcoming general meeting. In addition, upon the recommendation of the audit committee, the Board has proposed to appoint Zhongzheng Tianheng CPA Limited as the Company's new auditor following BDO's resignation, subject to approval by the shareholders at the Company's extraordinary general meeting.
Related Articles

ALI HEALTH (00241) grants a total of 7.6725 million restricted share units.

TIANJIN CAPITAL (01065) has been released from pledge by controlling shareholder Tianjin Municipal Investment for 76 million unrestricted tradable A shares.

JIUYUAN GENE (02566) repurchased 3,600 shares for HK$19,400 on September 15.
ALI HEALTH (00241) grants a total of 7.6725 million restricted share units.

TIANJIN CAPITAL (01065) has been released from pledge by controlling shareholder Tianjin Municipal Investment for 76 million unrestricted tradable A shares.

JIUYUAN GENE (02566) repurchased 3,600 shares for HK$19,400 on September 15.

RECOMMEND





